Posted inHealth FDA Scientists Clash With Deregulatory Push Over Unproven Peptides FDA scientists clash with political reformers over the safety risks of reintroducing unproven peptide therapies to the market. Posted by srkanalytics.srk@gmail.com July 24, 2026
